ScripWho: Skyhawk Therapeutics and Merck KGaA What: Skyhawk, which discovers and develops small molecules that modulate RNA expression, entered into a strategic research collaboration with Merck KGaA to
In VivoIsraeli-American startup Briya has launched AIRE, an AI-powered research assistant designed to help pharmaceutical companies and academic researchers analyze clinical data more efficiently. The platfo
ScripUltragenyx Says CRL Discussions ‘Productive’ Ultragenyx received a complete response letter for UX111, a gene therapy for patients with the rare terminal neurodegenerative disease Sanfilippo syndrome
ScripBiogen was forecasting another year of sales and earnings declines in 2025 as the company resets its business away from mature multiple sclerosis drugs toward a portfolio of newer growth drivers, but